SPI

SPI handeln
18.551,09 PKT +155,85 PKT +0,85 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN 998750

ISIN CH0009987501


Analysen zu SPI-Werten

Datum Rating Analyst
27.09.10 Adecco SA buy Vontobel Research
27.09.10 Swiss Life neutral Goldman Sachs Group Inc.
24.09.10 Adecco SA buy Vontobel Research
24.09.10 Mikron hold Vontobel Research
24.09.10 Novartis buy Vontobel Research
23.09.10 Novartis overweight Morgan Stanley
23.09.10 Adecco SA buy Vontobel Research
24.09.10 Novartis buy Nomura
23.09.10 Novartis neutral Goldman Sachs Group Inc.
23.09.10 Novartis kaufen Independent Research GmbH
22.09.10 Novartis buy Vontobel Research
21.09.10 Holcim hold Société Générale Group S.A. (SG)
20.09.10 Sonova outperform Credit Suisse Group
20.09.10 Nestlé kaufen Hamburger Sparkasse AG (Haspa)
20.09.10 Sulzer buy Vontobel Research
20.09.10 Kühne + Nagel International buy Vontobel Research
20.09.10 Ascom buy Vontobel Research
20.09.10 Novartis hold Vontobel Research
20.09.10 Adecco SA buy Vontobel Research
20.09.10 SGS SA hold Vontobel Research
20.09.10 BB Biotech kaufen Hamburger Sparkasse AG (Haspa)
17.09.10 Galenica buy Vontobel Research
17.09.10 SGS SA hold Vontobel Research
16.09.10 Kühne + Nagel International overweight Morgan Stanley
16.09.10 Orell Fuessli hold Vontobel Research
16.09.10 Holcim buy Vontobel Research
15.09.10 Addex Therapeutics hold Vontobel Research
15.09.10 dormakaba buy Vontobel Research
15.09.10 Holcim buy Vontobel Research
15.09.10 UBS buy Vontobel Research
14.09.10 SHL Telemedicine buy Vontobel Research
14.09.10 SGS SA hold Vontobel Research
14.09.10 Santhera Pharmaceuticals hold Vontobel Research
14.09.10 Sulzer buy Vontobel Research
13.09.10 Nestlé buy Vontobel Research
13.09.10 ABB (Asea Brown Boveri) hold Vontobel Research
13.09.10 ABB (Asea Brown Boveri) sell Société Générale Group S.A. (SG)
13.09.10 Geberit hold Vontobel Research
13.09.10 ARYZTA buy Vontobel Research
13.09.10 Novartis hold Vontobel Research